EMPAGEN MXR 10/1000MG TABLET

EMPAGEN MXR 10/1000MG TABLET is a combination medication used to treat type 2 diabetes. It contains Empagliflozin and Metformin HCI Extended Released release as active ingredients.

Description:

• Empagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that helps control blood sugar levels by blocking glucose reabsorption in the kidneys.
• Metformin hydrochloride extended release is a biguanide that improves insulin sensitivity and reduces glucose production in the liver, with a prolonged release mechanism for sustained effects.

Uses:

• To control high blood sugar levels in patients with type 2 diabetes.
• To reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.

Benefits:

• Improves glycemic control by reducing glucose production in the liver and increasing insulin sensitivity.
• Provides sustained effects for improved glycemic control.
• Lowers the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease.

Side Effects:

• Common side effects include nausea, diarrhea, abdominal pain, and vomiting.
• Other side effects may include urinary tract infections, genital fungal infections, dehydration, and hypoglycemia (low blood sugar).

When not to use:

• If you have type 1 diabetes.
• If you have severe kidney problems.
• If you have liver problems.
• If you are pregnant or breastfeeding.

It is important to inform your doctor of any medical conditions, allergies, or medications you are taking before starting treatment with EMPAGEN MXR 10/1000MG TABLET. Your doctor may need to adjust the dose or monitor you more closely for side effects.

Note: This information is not exhaustive and does not cover all possible precautions, side effects, or interactions. Please consult your doctor or healthcare provider for more information.